Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 32, 1861-1863, September 1, 1972]
© 1972 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wolff, G. L.
Right arrow Articles by Pitot, H. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wolff, G. L.
Right arrow Articles by Pitot, H. C.

Variation of Hepatic Malic Enzyme Capacity with Hepatoma Susceptibility in Mice of Different Genotypes1

George L. Wolff2 and Henry C. Pitot3

The Institute for Cancer Research, Fox Chase, Philadelphia, Pennsylvania 19111, and McArdle Laboratory for Cancer Research, University of Wisconsin Medical School, Madison, Wisconsin 53706

The incidence of spontaneous hepatoma in yellow and black male mice of the inbred YS/Wf and VY/Wf strains was determined. Among YS males, tumors were found in 11% of the yellow (Ay/a) and in 3% of the black (a/a) animals. Within the VY strain, tumors occurred in 24% of the yellow (A{upsilon}y/a) and in 13% of the black (a/a) males.

Among the four strain-genotype categories, the incidence at 12 to 16 months of age paralleled the catalytic capacity of hepatic malic enzyme at 8 and 14 weeks of age.

1 The research described in this report involved animals maintained in animal care facilities fully accredited by the American Association for Accrediation of Laboratory Animal Care.

2 Supported by Grants CA-06927 and RR-05539 from the NIH and by an appropriation from the Commonwealth of Pennsylvania.

3 Supported by grants from the National Cancer Institute (CA-07175) and the American Cancer Society (E-588).

Received 11/ 1/71. Accepted 5/24/72.




This article has been cited by other articles:


Home page
Exp. Biol. Med.Home page
G. L. Wolff, J. S. Stanley, M. E. Ferguson, P. M. Simpson, M. J. J. Ronis, and T. M. Badger
A BRIEF COMMUNICATION: Agouti Signaling Protein Stimulates Cell Division in "Viable Yellow" (Avy/a) Mouse Liver
Experimental Biology and Medicine, November 1, 2007; 232(10): 1326 - 1329.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
G. L. WOLFF, D. W. ROBERTS, and K. G. MOUNTJOY
Physiological consequences of ectopic agouti gene expression: the yellow obese mouse syndrome
Physiol Genomics, November 11, 1999; 1(3): 151 - 163.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1972 by the American Association for Cancer Research.